Voloridge Investment Management
TVTX icon

Voloridge Investment Management’s Travere Therapeutics TVTX Stock Holding History

Voloridge Investment Management’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.39M Sell
114,268
-753,354
-87% -$22.5M 0.01% 751
2025
Q4 		$33.2M Sell
867,622
-16,050
-2% -$522K 0.12% 220
2025
Q3 		$21.1M Buy
883,672
+139,018
+19% +$2.61M 0.07% 338
2025
Q2 		$11M Sell
744,654
-436,440
-37% -$7.23M 0.04% 522
2025
Q1 		$21.2M Buy
1,181,094
+173,897
+17% +$3.53M 0.08% 339
2024
Q4 		$17.5M Buy
1,007,197
+253,402
+34% +$4.48M 0.06% 390
2024
Q3 		$10.5M Buy
+753,795
New +$7.85M 0.04% 570
2023
Q4 		– Sell
-17,161
Closed -$153K – 1488
2023
Q3 		$153K Buy
+17,161
New +$242K ﹤0.01% 1334
2023
Q2 		– Sell
-35,617
Closed -$801K – 1573
2023
Q1 		$801K Buy
+35,617
New +$757K ﹤0.01% 1164
2022
Q2 		– Sell
-146,411
Closed -$3.77M – 1642
2022
Q1 		$3.77M Buy
146,411
+76,848
+110% +$2.04M 0.02% 735
2021
Q4 		$2.16M Buy
+69,563
New +$1.96M 0.01% 1045
2020
Q4 		– Sell
-53,807
Closed -$993K – 1572
2020
Q3 		$993K Buy
53,807
+5,687
+12% +$111K 0.01% 939
2020
Q2 		$982K Buy
+48,120
New +$766K 0.01% 856
2020
Q1 		– Sell
-25,178
Closed -$358K – 1408
2019
Q4 		$358K Sell
25,178
-30,104
-54% -$385K 0.01% 890
2019
Q3 		$641K Buy
+55,282
New +$914K 0.01% 741
2015
Q4 		– Sell
-12,209
Closed -$247K – 307
2015
Q3 		$247K Buy
+12,209
New +$362K 0.01% 259

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Voloridge Investment Management's TVTX Position: Q1 2026 in Review

Voloridge Investment Management reduced its Travere Therapeutics (TVTX) stake by 87% in Q1 2026, selling an estimated $22.5M and leaving 114,268 shares worth $3.39M. The position accounts for 0.01% of the portfolio, ranked #751.

Voloridge Investment Management first reported a position in TVTX in Q3 2015 and has held it in 16 quarters since. The position peaked at $33.2M in Q4 2025. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

  • Voloridge Investment Management held 114,268 shares of Travere Therapeutics worth $3.39M as of Q1 2026.
  • Voloridge Investment Management sold 753,354 Travere Therapeutics shares in Q1 2026, an estimated $22.5M.
  • Travere Therapeutics made up 0.01% of Voloridge Investment Management's portfolio in Q1 2026, its #751 holding.
  • Voloridge Investment Management first reported a position in Travere Therapeutics in Q3 2015 and has held it in 16 quarters since.
  • Voloridge Investment Management's Travere Therapeutics position peaked at $33.2M in Q4 2025.
  • 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.